Novartis eye drug franchise takes hit with failed Fovista studies
The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel, Switzerland October 22, 2013. REUTERS/Arnd Wiegmann/File Photo Swiss drugmaker Novartis’s bid to bolster its eye drug portfolio suffered a setback on Monday when it announced combining ... More »
